Success Stories: EB1A Approval Secured for Assistant Professor Driving Innovation in Medicinal Chemistry despite RFE

Client’s Testimonial:

“I express my deepest gratitude for all your hard work and expertise in handling my EB-1A petition. Receiving the approval notice was an incredibly emotional moment for me. This achievement would not have been possible without your meticulous attention to detail, strategic guidance, and unwavering support. The professionalism and dedication of your entire team are truly commendable. Thank you again for making this dream a reality.”

On September 8^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for an Assistant Professor in the Field of Medicinal Chemistry (Approval Notice).

General Field: Medicinal Chemistry

Position at the Time of Filing: Assistant Professor

Country of Origin: India

State of Residence at the Time of Filing: Texas

Approval Notice Date: September 8^th, 2025

Processing Time: 18 months and 18 days

Case Summary:

We are pleased to announce the approval of an EB1A (Alien of Extraordinary Ability) petition for an assistant professor from India in the field of medicinal chemistry. A Ph.D. in chemistry and a solid academic background in chemical and biological sciences have enabled the client to establish a career focused on innovative drug discovery and molecular design. The petition was filed on February 21, 2024, and approved on September 8, 2025. With our help, the client secured success despite receiving an RFE.

Research Focus and Contributions:

Our client’s work in medicinal chemistry has focused on designing and synthesizing novel chemical entities to address some of today’s most pressing public health challenges. His research spans:

Developing antimicrobial, antimalarial, antifungal, and antifilarial compounds to combat drug resistance.
Creating covalent organic framework-based membranes for water desalination and dialysis, contributing to sustainable solutions for global healthcare needs.
Innovating synthetic pathways for antidiabetic agents, particularly iminosugars, to reduce costs and improve accessibility of treatment for diabetes.

These contributions have been recognized for their originality and practical significance, shaping drug discovery and molecular design strategies.

Scholarly Output and Impact:

The client has authored 28 peer-reviewed journal articles, in addition to a book, a book chapter, and two patent applications. His publications have appeared in selective venues, confirming the high quality of his work.

His research has accumulated over 360 citations, placing him among the top 1% of highly cited authors in medicinal chemistry in recent years. This citation record demonstrates the widespread reliance of international peers on his findings for advancing their own studies.

Peer Review and Editorial Service:

Beyond authorship, the client has completed at least 25 peer reviews for respected journals in chemistry and medicinal sciences. He has also been invited to serve as a guest editor and editorial board member, roles that underscore his status as a trusted authority in the field.

Expert Endorsements:

The petition was supported by six letters from internationally recognized experts who emphasized both the originality and applied impact of his research. As one recommender observed:

“Through his discoveries, [the client] has established himself as one of the leading experts in medicinal chemistry, particularly in the molecular development of effective drugs to treat several fatal health conditions that are prominent in the United States.”

EB1A Approval and Outlook:

By demonstrating his significant publication record, strong citation history, substantial peer review activity, and original scientific contributions, NAILG successfully showed that the client has risen to the very top of the field of medicinal chemistry. With his EB1A approval, he is now positioned to continue developing life-saving therapeutic compounds and innovative molecular frameworks in the United States.

At NAILG, we congratulate our client on this achievement and look forward to his continued contributions to the advancement of medicinal chemistry.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.